Lack of Physician Education, Genetic Counseling Could Ruin Value Proposition of PGx Testing, Insurer Says

The limited ability of physicians to determine which patients should receive certain genetic tests often compromises the value proposition of pharmacogenetically guided medicine — even if the diagnostic is shown to be clinically useful and analytically sound, according to a UnitedHealthcare official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.